What Is Gvoke Used For?
Gvoke (glucagon injection) treats severe hypoglycemia—dangerously low blood sugar—in patients 2 years and older with diabetes. It raises blood sugar quickly when oral carbs aren't possible, such as during unconsciousness.[1]
Is It a Diabetes Treatment or Cure?
No, Gvoke does not treat diabetes itself. Diabetes management focuses on insulin, diet, or other glucose-lowering drugs. Gvoke is an emergency rescue for hypoglycemia, a common diabetes complication from excess insulin or missed meals.[1][2]
How Does It Work for Hypoglycemia?
Glucagon prompts the liver to release stored glucose into the bloodstream within 10-15 minutes. It's prefilled, ready-to-use, unlike older kits needing mixing. Administer via thigh injection; patients recover enough for oral intake soon after.[1]
Who Needs Gvoke and When?
Primarily type 1 diabetes patients on insulin, at risk of lows. Also used in type 2 on insulin or sulfonylureas. Carry it if you have had severe lows before. Not for chronic use—train caregivers on delivery.[2]
Alternatives to Gvoke
- Baqsimi: Nasal glucagon spray, no needle.
- Zegalogue: Ready-to-inject auto-injector.
- Traditional kits: Glucagon powder + syringe, less user-friendly.
All target severe hypoglycemia; choice depends on ease and insurance.[1][3]
Side Effects and Risks
Common: nausea, vomiting. Rare: high blood pressure, allergic reactions. Avoid if pheochromocytoma or insulinoma. Overuse risks rebound highs. Store refrigerated.[1]
Cost and Availability
Prescription-only. List price around $300 per kit (single-dose); copays vary by insurance. Generic glucagon emerging, potentially lowering costs.[3]
[1]: Gvoke official site
[2]: FDA label for Gvoke
[3]: Drugs.com - Glucagon options